Atlas Trials

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Clinical trial NCT06221657 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06221657
Sponsor
Yonsei University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication
Start date
2024-02-01
Primary completion
2026-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.